Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

KAI1 functions as a negative regulator of angiogenesis

ABSTRACT: KAI1 functions as a negative regulator of angiogenesis

PROVIDER: PRJNA471496 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

KAI1 functions as a negative regulator of angiogenesis

Project description:We sequenced mRNA from WT and Kai1 KO PVCs

2021-09-22 | GSE114465 | GEO

A peptide CORO1C-47aa encoded by circ-0000437 functions as a negative regulator in endometrium tumor angiogenesis

Project description:Circular RNAs (circRNA) are a novel class of widespread non-coding RNAs (ncRNAs) that regulate gene expression in mammals. Recent studies demonstrate that functional peptides can be encoded by short open reading frames (sORFs) in ncRNAs, including circRNAs. In this study, through deep RNA sequencing on human endometrial cancer (EC) samples and their paired adjacent normal tissues, we uncovered that the circRNA hsa-circ-0000437 is significantly reduced in EC compared to matched paracancerous tissue. The hsa-circ-0000437 contains a sORF encoding a functional peptide termed as CORO1C-47aa. Overexpression of CORO1C-47aa is capable of inhibiting angiogenesis at the initiation stage by suppressing endothelial cell proliferation, migration, and differentiation through competing with TACC3 to bind to ARNT and suppress VEGF. The anti-tumor effects of CORO1C-47aa on EC progression suggest that CORO1C-47aa has a potential value in anti-carcinoma therapies and deserves further investigation.

2022-02-17 | PXD026046 | Pride

Soluble Neuregulin1 is a negative regulator of myelination

Project description:Soluble Neuregulin1 is a negative regulator of myelination

| PRJNA412366 | ENA

ABIN1 is a negative regulator of effector functions in cytotoxic T cells

Project description:The main objective of the data analysis presented here is the investigation of the role of ABIN1 in antigenic responses of primary T cells. For this purpose, T cells from ABIN1-deficient mouse strain (GTKO) and WT mice were analyzed under different activation conditions. The effect of P38 MAPK inhibitor SB203580 (p38 inhibitor/p38i) was also analyzed. The results suggest that ABIN1 is a negative regulator of TCR-mediated activation and expression of the key effector molecules in primary CD8+ T cells, at least partly via the inhibition of the p38 pathway.

2023-11-01 | GSE245397 | GEO

Mindbomb1 is a Novel Negative Regulator of BMP Signaling

Project description:Mindbomb1 is a Novel Negative Regulator of BMP Signaling.

2024-07-02 | MSV000095215 | MassIVE

Hypoxia-mediated regulation of histone demethylases affects angiogenesis associated functions in endothelial cells

Project description:Hypoxia-mediated regulation of histone demethylases affects angiogenesis associated functions in endothelial cells

| PRJNA586868 | ENA

SAM68 is a splicing regulator in triple negative breast cancer

Project description:SAM68 is a splicing regulator in triple negative breast cancer

| PRJNA590793 | ENA

Bach2 is a critical negative regulator of Tfh cell differentiation

Project description:Bach2 is a critical negative regulator of Tfh cell differentiation

| PRJNA508402 | ENA

GLUTAMINE METABOLISM VIA TRANSAMINATION REGULATES VEGFR2 TRANSLATION DURING ANGIOGENESIS

Project description:Angiogenesis, the formation of new blood vessels from pre-existing ones, is a complex and demanding biological process that plays an important role in physiological as well as pathological settings such as cancer and ischemia. Given its critical role, the regulation of endothelial growth factor receptor (e.g. VEGFR2, FGFR1) represents important mechanisms for the control of angiogenesis. Recent evidences support cell metabolism as a critical regulator of angiogenesis. However, it is unknown how glutamine metabolism regulates growth factor receptor expression. Here, by using genetic and pharmacological approaches, we show that glutaminolysis and glutamate-dependent transaminases (TAs) support alpha-ketoglutarate (αKG) levels and are critical regulators of angiogenic response during pathological conditions. Indeed, the endothelial specific blockage of GLS1 impairs ischemic and tumor angiogenesis by suppressing VEGFR2 translation via mTORC1-dependent pathway. Lastly, we discover that ECs catabolized the glutamine-derived glutamate via phosphoserine aminotransferase 1 (PSAT1) as crucial to support VEGFR2 translation. These findings identify glutamine anaplerosis and TA activity as a critical regulator of growth factor receptor translation in normal and pathological angiogenesis. We anticipate our studies to be a starting point for novel anti-angiogenesis approaches based on GLS1/PSAT1 inhibitor treatments to overcome anti-VEGF therapies resistance.

2022-04-22 | PXD022379 | Pride